Studien

Evinec Safety and Tolerability of Everolimus as second–line treatment in poorly differentiated neuroendocrine carcinoma / neuroendocrine carcinoma G3 according to WHO 2010 and neuroendocrine tumor G3 AIO-NET-0112 · Studie beendet Studie anzeigen

MATEO Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer (MATEO) AIO-YMO-0111 · Studie beendet Studie anzeigen

NEOLAP Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer (NEOLAP) AIO-PAK-0113 · Rekrutierung beendet Studie anzeigen

IMPALA Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment (IMPALA) AIO-KRK-0313 · Studie beendet Studie anzeigen

POWER Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable, Advanced or Metastatic Esophageal Squamous Cell Cancer (POWER) AIO-STO-0309 · Studie beendet Studie anzeigen

AIO-LQ-0110 Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer AIO-LQ-0110 · Studie beendet Studie anzeigen

VOLFI FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI) AIO-KRK-0109 · Studie beendet Studie anzeigen

Sequenz-therapie Randomized three arm phase III trial on induction and reinduction treatment with FOLFOX (5-fluorouracil, folinic acid and oxaliplatin regimen) or XELOX (capecitabine and oxaliplatin regimen) both with bevacizumab until progression or with or without maintenance treatment with bevacizumab alone for first-line treatment of patients with metastatic colorectal cancer AIO-KRK-0207 · Studie beendet Studie anzeigen